Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

*Product:*	Clindamycin-hameln (300mg/2ml)
Active Ingredient:	Clindamycin phosphate 178.23mg/mL equivalent to clindamycin 150mg/mL
Dosage Form:	Solution for injection
New Zealand Sponsor:	Max Health Limited
Manufacturer:	Siegfried Hameln GmbH, Hameln, Germany

*Product:*	Clindamycin-hameln (600mg/4ml)
Active Ingredient:	Clindamycin phosphate 178.23mg/mL equivalent to clindamycin 150mg/mL
Dosage Form:	Solution for injection
New Zealand Sponsor:	Max Health Limited
Manufacturer:	Siegfried Hameln GmbH, Hameln, Germany

*Product:*	Codral Mucus Cough Forte Strength
Active Ingredients:	Bromhexine hydrochloride 0.8mg/mL Guaifenesin 20mg/mL
Dosage Form:	Oral solution
New Zealand Sponsor:	Johnson & Johnson (New Zealand) Limited
Manufacturer:	Shanghai Johnson & Johnson Pharmaceuticals Limited, Shanghai, China

Dated this 22nd day of August 2022.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule